Why Executive Accountability Matters
An Own Risk and Solvency Assessment (ORSA) is meant to inform how an insurer understands and manages its own risks and solvency. That purpose is weakened if it becomes only a technical report or a document assembled for submission. Senior executives need to make sure the assessment is connected to management’s view of the business, its material risks, and its decisions. Their accountability is not replaced by the work of specialists or by board review.
This tutorial focuses on who leads and owns ORSA within executive management. It distinguishes executive sponsorship from the board’s oversight role and from the technical contributions that support the assessment. The distinction is aligned with the CAS Exam 9 (Risk Management for Actuaries) syllabus.
The named sponsor may be the chief executive, a designated senior executive, or another role established by the insurer’s governance arrangements. There is no single title that applies to every insurer. What matters is that the sponsor has sufficient authority to convene the relevant executives, resolve or escalate cross-business issues, and ensure that conclusions receive management attention. Applicable law, regulation, and the insurer’s own governance documents determine any specific required roles.
Accountability, Oversight, and Technical Contribution
These roles interact, but they answer different questions. Executive accountability asks: Who ensures that management owns and acts on the assessment? Board oversight asks: How does the board challenge management’s view and exercise its governance responsibilities? Technical contribution asks: Who supplies analyses, methods, data, or specialist judgment used in the assessment? Confusing these questions can make it unclear who is expected to decide what happens when ORSA identifies a material concern.
| Role | Primary ORSA contribution | What the role does not replace |
|---|---|---|
| Executive sponsor and senior management | Set expectations for the assessment, ensure relevant management views are brought together, consider conclusions, and connect them to decisions or escalation. | Board oversight or the need for sound technical analysis. |
| Board | Oversee and challenge management’s assessment and exercise its governance responsibilities. | Management’s responsibility to prepare, integrate, and act on its own assessment. |
| Technical contributors | Provide analysis, assumptions, data, interpretation, and other specialist input within their assigned remit. | Executive responsibility for the overall assessment and management response. |
A useful responsibility map makes the boundaries visible. For each significant ORSA activity, it records the accountable executive, the board’s oversight point, the technical contribution required, and evidence that the executive responsibility was exercised. This is not a substitute for an insurer’s formal governance documents. It is a practical way to expose gaps, duplicate claims of authority, and tasks that have an owner for the analysis but no management owner for the conclusion.
Building a Responsibility Map
Start with consequential activities rather than job titles alone. A map that says only “management is responsible” may be too vague to resolve a disagreement or identify an escalation route. A map that assigns every technical task to the executive sponsor is equally unhelpful: it mistakes accountability for authorship.
Use a specific item, such as deciding whether a material solvency concern requires management action, rather than a broad label such as “ORSA.”
Name the executive role expected to ensure that the issue is considered and brought to the appropriate management decision point.
Identify the board’s oversight point and the technical input needed. Do not treat either as a replacement for executive accountability.
State what would demonstrate executive consideration, and where the issue goes if executives cannot resolve it or if it needs board attention.
The reasoning behind this sequence is straightforward. ORSA conclusions can affect management choices, while technical work often informs but does not itself make those choices. Therefore, a map must connect the technical evidence to an executive who can ensure it is considered and to the governance route for any matter requiring oversight. If the map identifies only the analyst, it leaves the management response unassigned. If it identifies only the board, it can blur management’s role in bringing a considered assessment forward.
Evidence need not be limited to a signature on the final document. Depending on the insurer’s processes, evidence may include a record that executives discussed a material conclusion, challenged an assumption, considered management options, assigned a follow-up action, or escalated an unresolved matter. The point is not to prescribe a particular format. It is to make the exercise of accountability observable and traceable.
Worked Examples
Worked Example: Mapping a Material Solvency Concern
A hypothetical insurer’s assessment identifies a stress under which projected available capital is $128 million. Management’s stated internal threshold is $140 million. A technical team has completed the analysis, but no executive has been identified to decide how management should respond. Map the roles and identify the gap.
Step 1: Identify the decision. The relevant activity is not merely calculating the stressed capital amount. It is deciding how management will respond to the indicated threshold breach and whether the matter requires escalation.
Step 2: Compare the values. The projected amount is $128 million and the threshold is $140 million. The shortfall is $140 million − $128 million = $12 million. The result is below the stated threshold.
Step 3: Assign the roles. The designated executive sponsor, with the relevant senior management, is accountable for ensuring that the result and its implications are considered and that a management response is determined or escalated. The board’s role is oversight and challenge at the appropriate point. The technical team contributes the analysis and any supporting explanation; it does not own the management response simply because it produced the number.
Step 4: State the gap and evidence. The missing item is an accountable executive for the response. Evidence could include a record of executive consideration of the $12 million shortfall, the decision or escalation that followed, and any assigned next step. The calculation is checked: $128 million + $12 million = $140 million.
Method and mistake avoided. Work from the decision backward to the executive who must ensure it is addressed, then distinguish that role from the analyst and board. A common mistake is to assign ownership to the technical team because it generated the result. That would leave the management decision without a clear accountable executive.
Worked Example: Resolving Conflicting Executive Views
In a hypothetical insurer, one executive believes a proposed expansion is consistent with the ORSA conclusion; another believes it could materially increase risk. The technical analysis estimates an additional $18 million of capital need under the expansion scenario. The proposed management tolerance for the relevant capital impact is $15 million. Explain how the responsibility map should handle the disagreement.
Step 1: Separate evidence from decision. The estimated $18 million is technical input. The management question is whether to proceed, change the proposal, seek further analysis, or escalate the issue. The calculation alone does not select an option.
Step 2: Compare the estimate with the tolerance. The excess is $18 million − $15 million = $3 million. The estimated impact is $3 million above the stated tolerance. This comparison is a signal for management consideration, not by itself a conclusion about whether expansion must stop.
Step 3: Map accountability and oversight. The executive sponsor ensures the disagreement and its basis are brought to the appropriate management decision point. Relevant executives consider the competing views and determine a response or an escalation path. Technical contributors explain the analysis and its limitations. The board exercises oversight where the matter is brought forward under the insurer’s governance arrangements; it should not be treated as the author of management’s initial assessment.
Step 4: Identify evidence. A useful record would show the $18 million estimate, the $15 million tolerance, the $3 million excess, the material points of disagreement, and the resulting management decision or escalation. The arithmetic checks because $15 million + $3 million = $18 million.
Method and mistake avoided. Separate a threshold comparison from the decision it informs, then assign the decision process to management. A common mistake is to assume that exceeding a tolerance automatically dictates a particular action. The map instead makes clear who must consider the result and where unresolved concerns go.
Worked Example: Testing an Executive Delegation
A hypothetical insurer names its finance executive as ORSA sponsor. The sponsor delegates preparation of the assessment to a specialist team and receives a completed draft. At a scheduled executive discussion, the sponsor is absent, no alternate has been named, and the draft is sent directly for board review. Is the responsibility arrangement sufficient? Identify the missing steps.
Step 1: Distinguish delegation of work from accountability. Delegating preparation is compatible with executive accountability. It does not establish that an executive has ensured the conclusions were considered by management.
Step 2: Identify the process break. The sponsor is absent, and no alternate is assigned. Consequently, there is no identified executive ensuring that management considers the draft before it is sent onward. Board review may still occur, but it does not fill that management-level gap.
Step 3: Correct the map. The insurer should identify how the accountable executive will ensure management consideration, including a suitable alternate or another defined route if the sponsor is unavailable. The map should also identify the technical team as preparer, not as the substitute management owner.
Step 4: Specify evidence. Evidence would show that an authorized executive considered the assessment and its material conclusions before the appropriate board oversight point, or documented why an alternate route was used. No numerical calculation is needed: the failure is a missing assigned management responsibility, not a difference between two quantified estimates.
Method and mistake avoided. Test whether there is a continuous line from preparation through management consideration to oversight. A common mistake is to treat delivery of a completed draft to the board as proof that executive accountability was exercised. Delivery shows transmission, not necessarily management consideration.
Common Accountability Traps
- “The specialist team owns ORSA because it prepared the report.” Preparation is a contribution. The executive sponsor remains accountable for ensuring management considers the assessment and its implications.
- “The board owns the assessment because it reviews it.” Board oversight does not eliminate management’s responsibility to form and present its own assessment.
- “The sponsor is accountable, so the sponsor must perform every analysis.” Accountability and technical execution are different. Clear delegation can support effective leadership, provided it does not leave management decisions ownerless.
- “A signature proves meaningful consideration.” A sign-off may be part of a process, but a responsibility map should also make clear what decision or review the executive is expected to undertake.
- “A named sponsor is enough.” A name without authority, defined decision responsibilities, or an escalation route may not resolve who acts when executives disagree or a material issue arises.
Check Your Understanding
For each hypothetical case, identify the executive accountability issue and distinguish it from board oversight or technical contribution.
- A technical group estimates a $24 million capital impact from a proposed product change. Management’s stated review threshold is $20 million. What is the amount above the threshold, and who should ensure the management response is considered? (Answer: $4 million above; the accountable executive sponsor and relevant senior management must ensure the response is considered or escalated.)
- A board member requests a different stress analysis after reviewing an ORSA draft. Who remains accountable for arranging management’s consideration of the revised analysis, and what is the board member’s role? (Answer: The accountable executive sponsor remains responsible for ensuring management consideration; the board member is exercising oversight and challenge.)
- An executive sponsor assigns a technical team to draft the report and assumes that assignment completes the sponsor’s responsibility. What remains to be demonstrated? (Answer: That an executive ensured management considered the assessment’s conclusions and response, with a clear escalation route where needed.)
- A material disagreement remains between two executives about whether a strategic proposal is consistent with the insurer’s own risk view. What should the responsibility map identify? (Answer: The executive accountable for ensuring the disagreement reaches the appropriate management decision point, the technical evidence supporting the views, and the route for escalation or board oversight.)
- A draft is signed by a senior executive, but the responsibility map does not say what the signature represents or what happens to unresolved issues. What are the two governance gaps? (Answer: The map does not define the executive’s review or decision responsibility, and it does not specify an escalation route for unresolved issues.)